Streptococcus vaccine compositions and methods of using the same
Abstract
The present invention provides methods and compositions for the stimulation of immune responses. In particular, the present invention provides immunogenic nanoemulsion compositions and methods of using the same for the induction of immune responses (e.g., innate and/or adaptive immune responses (e.g., for generation of host immunity against a bacterial species of the genus Streptococcus (e.g., Streptococcus pneumoniae ))). Compositions and methods of the present invention find use in, among other things, clinical (e.g. therapeutic and preventative medicine (e.g., vaccination)) and research applications.
Claims
exact text as granted — not AI-modifiedWe claim:
1 . An immunogenic composition comprising a nanoemulsion and an immunogen, wherein said nanoemulsion comprises a non-ionic surfactant, ethanol, cetylpyridinium chloride (CPC), oil and water, and wherein said immunogen comprises killed whole cell Streptococcus pneumoniae.
2 . The immunogenic composition of claim 1 , wherein the composition comprises between 10 6 and 10 8 CFU of killed Streptococcus pneumonia.
3 . The immunogenic composition of claim 1 , wherein the composition comprises 10 6 CFU of killed Streptococcus pneumonia.
4 . The immunogenic composition of claim 1 , wherein the composition comprises 10 8 CFU of killed Streptococcus pneumonia.
5 . The immunogenic composition of claim 1 , wherein the Streptococcus pneumoniae cells are killed via mixing with said nanoemulsion.
6 . The immunogenic composition of claim 1 , wherein the Streptococcus pneumoniae cells are killed via mixing with ethanol.
7 . An immunogenic composition comprising a nanoemulsion and a Streptococcus pneumoniae immunogen, wherein said nanoemulsion comprises a non-ionic surfactant, ethanol, cetylpyridinium chloride (CPC), oil and water.
8 . The immunogenic composition of claim 7 , wherein the Streptococcus pneumoniae immunogen is selected from the group consisting of Streptococcus pneumoniae polysaccharide, Streptococcus pneumoniae protein, killed whole cell Streptococcus pneumonia , and a combination thereof.Join the waitlist — get patent alerts
Track US2014193461A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.